Lung Cancers Enrolling by Invitation Phase 2 Trials for Capecitabine (DB01101)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

DBCOND0072929 (Lung Cancers)Enrolling by Invitation2 IdentifierTitlePurposeDrugs
NCT02955940An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of RuxolitinibTreatment